Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy Paris, June 10, 2026. Sanofi today...
82% of subjects achieved an MCID in their MG-ADL with a mean >4 point improvement in MG-ADL observed in Phase...
– Successful End-of-Phase 2 meeting with FDA agreeing on key elements of the proposed Phase 3 design, including study population,...
HAMILTON, Ontario, June 08, 2026 (GLOBE NEWSWIRE) -- A newly released national report is calling for urgent, coordinated action to...
Recognition honors Sun Life's commitment to expanding health access through community-based investingWELLESLEY, Mass. and NEW YORK, June 4, 2026 /PRNewswire/...
VIENNA, Va., June 4, 2026 /PRNewswire/ -- The National Academy of Elder Law Attorneys (NAELA), the leading professional association dedicated...
Designation is supported by an exploratory analysis from the Phase 1b study showing that some children with SMA previously treated...
Majority of patients met the American College of Rheumatology improvement criteria (ACR70) response by Week 36 Single-dose of miv-cel delivered...
Majority of patients met the American College of Rheumatology improvement criteria (ACR70) response by Week 36 Single-dose of miv-cel delivered...
Pharmacokinetic and pharmacodynamic data support quarterly subcutaneous BRIUMVI dosing regimen currently under evaluation in fully enrolled Phase 3 trial; Top-line...
Partnerships with the Medical University of South Carolina, Prisma Health, and the South Carolina Community Health Worker Association drive toward...
Partnerships with the Medical University of South Carolina, Prisma Health, and the South Carolina Community Health Worker Association drive toward...
Annual publication analyzes structural shifts reshaping claims management, includinglitigation, workforce transformation and evolving medical and vehicle challengesSAN DIEGO, June 2,...
Presentation explored motion-restoring alternatives for select patients with persistent pain or pseudoarthrosis following cervical fusion surgery BEVERLY HILLS, CA /...
Cone-Beam Computed Tomography Perfusion allows for more insights to support clear diagnosis and precise treatment of stroke patientsCollaboration supports the...
Cone-Beam Computed Tomography Perfusion allows for more insights to support clear diagnosis and precise treatment of stroke patientsCollaboration supports the...
First U.S. commercial cases establish LimiFlex as an outpatient, motion-preserving stabilization option SAN CARLOS, CA / ACCESS Newswire / May...
First U.S. commercial cases establish LimiFlex as an outpatient, motion-preserving stabilization option SAN CARLOS, CA / ACCESS Newswire / May...
– Alterity’s novel imaging and biomarker approach positions the Company at the forefront of clinical research in MSA – –...
Seasoned Biotech CFO with IPO and M&A track record joins as Company advances pivotal Phase 3 trial of sovateltide, RESPECT-ETB,...